Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,22 USD | +0,94% |
|
-0,62% | -7,98% |
Attività
Numero di dipendenti: 10
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 01/09/05 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 01/12/19 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 01/01/22 |
Stephen Machatha
PRN | Corporate Officer/Principal | 47 | 01/01/21 |
James A. Gow
PRN | Corporate Officer/Principal | - | 12/03/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 01/05/09 |
Martin Joyce
BRD | Director/Board Member | 70 | 01/10/13 |
Ben Bronstein
BRD | Director/Board Member | 74 | 01/06/10 |
Todd Brady
CEO | Chief Executive Officer | 52 | 01/09/05 |
Neal Walker
BRD | Director/Board Member | 54 | 01/06/13 |
Richard Douglas
CHM | Chairman | 71 | 13/09/16 |
Director/Board Member | 65 | 13/01/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 59 414 489 | 48 657 968 ( 81,90 %) | 0 | 81,90 % |
Coordinate società
Aldeyra Therapeutics, Inc.
131 Hartwell Avenue Suite 320
02421, Lexington
+781 761 4904
http://www.aldeyra.com![Indirizzo Aldeyra Therapeutics, Inc.(ALDX)](https://cdn.zonebourse.com/static/address/16253115.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-7,98% | 190 Mln | |
+18,21% | 122 Mrd | |
+19,31% | 112 Mrd | |
-23,94% | 19,33 Mrd | |
-18,45% | 16,17 Mrd | |
-18,77% | 15,6 Mrd | |
-49,33% | 14,65 Mrd | |
+57,70% | 14,34 Mrd | |
+6,80% | 14 Mrd | |
+126,22% | 11,29 Mrd |
- Borsa valori
- Azioni
- Azione ALDX
- Società Aldeyra Therapeutics, Inc.